These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31788977)

  • 1. Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways.
    Attwa MW; Kadi AA; Abdelhameed AS
    J Sep Sci; 2020 Feb; 43(4):708-718. PubMed ID: 31788977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive intermediates and bioactivation pathways characterization of avitinib by LC-MS/MS: In vitro metabolic investigation.
    Attwa MW; Kadi AA; Abdelhameed AS
    J Pharm Biomed Anal; 2019 Feb; 164():659-667. PubMed ID: 30472584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Fenebrutinib Metabolism and Bioactivation Using MS
    Alsibaee AM; Aljohar HI; Attwa MW; Abdelhameed AS; Kadi AA
    Molecules; 2023 May; 28(10):. PubMed ID: 37241965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach.
    Abdelhameed AS; Attwa MW; Kadi AA
    Drug Des Devel Ther; 2020; 14():5259-5273. PubMed ID: 33299299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural identification of imatinib cyanide adducts by mass spectrometry and elucidation of bioactivation pathway.
    Li AC; Yu E; Ring SC; Chovan JP
    Rapid Commun Mass Spectrom; 2014 Jan; 28(1):123-34. PubMed ID: 24285397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Belizatinib: Novel reactive intermediates and bioactivation pathways characterized by LC-MS/MS.
    Attwa MW; Kadi AA; Darwish HW
    J Pharm Biomed Anal; 2019 Jul; 171():132-147. PubMed ID: 30999224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS reveals the formation of iminium and quinone methide reactive intermediates in entrectinib metabolism: In vivo and in vitro metabolic investigation.
    Attwa MW; Kadi AA; Alrabiah H; Darwish HW
    J Pharm Biomed Anal; 2018 Oct; 160():19-30. PubMed ID: 30055343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation.
    Abdelhameed AS; Attwa MW; Kadi AA
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS:
    Attwa MW; Kadi AA; Abdelhameed AS
    RSC Adv; 2018 Nov; 8(68):38733-38744. PubMed ID: 35558335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS reveals the formation of reactive ortho-quinone and iminium intermediates in saracatinib metabolism: Phase I metabolic profiling.
    Attwa MW; Kadi AA; Darwish HW; Alrabiah H
    Clin Chim Acta; 2018 Jul; 482():84-94. PubMed ID: 29614307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism.
    Liu X; Lu Y; Guan X; Dong B; Chavan H; Wang J; Zhang Y; Krishnamurthy P; Li F
    Biochem Pharmacol; 2015 Sep; 97(1):111-21. PubMed ID: 26212543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive intermediates formation and bioactivation pathways of spebrutinib revealed by LC-MS/MS:
    Alsibaee AM; Aljohar HI; Attwa MW; Abdelhameed AS; Kadi AA
    Heliyon; 2023 Jun; 9(6):e17058. PubMed ID: 37484253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling.
    Attwa MW; Kadi AA; AlRabiah H; Darwish HW
    RSC Adv; 2019 Mar; 9(18):10211-10225. PubMed ID: 35520926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS.
    Attwa MW; Kadi AA
    RSC Adv; 2019 Oct; 9(57):32995-33006. PubMed ID: 35529145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial.
    Kim DW; Lee DH; Han JY; Lee J; Cho BC; Kang JH; Lee KH; Cho EK; Kim JS; Min YJ; Cho JY; An HJ; Kim HG; Lee KH; Kim BS; Jang IJ; Yoon S; Han O; Noh YS; Hong KY; Park K
    Lung Cancer; 2019 Sep; 135():66-72. PubMed ID: 31447004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways.
    Kadi AA; Attwa MW; Darwish HW
    RSC Adv; 2018 Jan; 8(3):1182-1190. PubMed ID: 35540908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
    Ma S; Subramanian R; Xu Y; Schrag M; Shou M
    Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites.
    Abdelhameed AS; Attwa MW; Kadi AA
    R Soc Open Sci; 2019 Aug; 6(8):190852. PubMed ID: 31598253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC-MS/MS:
    Kadi AA; Darwish HW; Abuelizz HA; Alsubi TA; Attwa MW
    R Soc Open Sci; 2019 Jan; 6(1):181714. PubMed ID: 30800400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-(Benzo[b]thiophen-4-yl)piperazine Ring Induced Bioactivation of Brexpiprazole in Liver Microsomes: Identification and Characterization of Reactive Conjugates Using Ultra-High-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry.
    Thakkar D; Kate AS
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):393-403. PubMed ID: 32002811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.